The Charlotte Woodward Organ Transplant Discrimination Prevention Act aims to prevent discrimination against individuals with disabilities in the organ transplant process. It prohibits healthcare providers and related entities from denying or limiting access to organ transplants solely based on a person's mental or physical disability. The bill requires that any consideration of a disability in transplant decisions must be based on an individualized medical evaluation. Additionally, it mandates reasonable modifications to policies to ensure accessibility for individuals with disabilities and provides a mechanism for expedited resolution of discrimination claims through the Department of Health and Human Services.
The National Down Syndrome Society (NDSS) has expressed strong support for the reintroduction of the Charlotte Woodward Organ Transplant Discrimination Prevention Act. They highlight that the legislation upholds and clarifies existing civil rights, ensuring that individuals with disabilities are not denied life-saving organ transplants solely due to their disability status. The NDSS emphasizes the bill's role in providing additional legal recourse for those who experience discrimination in the transplant process.
As of now, there is no significant negative media coverage regarding the Charlotte Woodward Organ Transplant Discrimination Prevention Act. Given the bill's focus on preventing discrimination and promoting equal access to organ transplants for individuals with disabilities, it is likely to receive broad bipartisan support. However, potential concerns could arise from healthcare providers or transplant centers regarding the implementation of the required policy modifications and the potential for increased administrative processes to handle discrimination claims.
The Charlotte Woodward Organ Transplant Discrimination Prevention Act, sponsored by Ashley Moody, does not show any direct industry overlaps with her top donor industries, which suggests a lower risk of conflicts of interest. However, significant lobbying activity in the healthcare sector, particularly from Fresenius Kabi USA LLC, which contributed $1,100,000, could raise questions about potential influences on the bill's provisions. Despite this, the absence of direct financial ties between the bill's subject matter and the sponsor's donors indicates that the risk of conflicts is relatively low. Voters should be aware that while there are substantial contributions from healthcare-related entities, the lack of direct overlap with the bill's focus mitigates potential concerns.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| FRESENIUS KABI USA LLC | FRESENIUS KABI USA LLC | $1,100,000 |
| CONSEJO COORDINADOR EMPRESARIAL | IQOM STRATEGIC ADVISORS, LLC | $140,000 |
| IVANHOE ATLANTIC (FORMERLY HIGH POWER EXPLORATION INC.) | YORKTOWN SOLUTIONS | $120,000 |
| SKYRYSE, INC. | SKYRYSE, INC. | $70,000 |
| AIS HEALTHCARE | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $20,000 |
| THE FERGUSON GROUP, LLC ON BEHALF OF WEST COUNTY WASTEWATER DISTRICT, CA | EARL STOCKDALE | undisclosed |
| THE FERGUSON GROUP, LLC FOR CITY OF OCEANSIDE CA | EARL STOCKDALE | undisclosed |
| THE FERGUSON GROUP, LLC ON BEHALF OF WARD & SMITH (FOR BALD HEAD ISLAND) | EARL STOCKDALE | undisclosed |
| THE FERGUSON GROUP, LLC ON BEHALF OF WARD & SMITH, PA (FOR HOLDEN BEACH, NC) | EARL STOCKDALE | undisclosed |
| CORE POWER (US) INC. | INVARIANT LLC | undisclosed |
| ICON TECHNOLOGY, INC. | INVARIANT LLC | undisclosed |
| HUBBS-SEAWORLD RESEARCH INSTITUTE | HAMMER ASSOCIATES, LLC | undisclosed |
| THE POLICY SHOP LLC | JAVELIN ADVISORS LLC | undisclosed |
| NATIONAL ALLIANCE OF HEALTHCARE PURCHASER COALITIONS | NATIONAL ALLIANCE OF HEALTHCARE PURCHASER COALITIONS | undisclosed |
| EARTHSHIP CORPORATION | RED DOOR CONSULTING, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
